Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Semaglutide (GLP-1 receptor agonist)2mg Injectable solution bulk supplier for pharma manufacturers

Semaglutide (Glp-1 Receptor Agonist)2Mg Injectable Solution Suppliers & Bulk Manufacturers

Available Forms: Injectable solution (prefilled pen)

Available Strengths: 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 2 mg/0.5 mL

Reference Brands: Ozempic(EU & US)

Category: Diabetes

Semaglutide is a GLP-1 receptor agonist that mimics the action of incretin hormones to enhance insulin secretion, suppress glucagon release, and slow gastric emptying, helping control blood sugar. It is used for type 2 diabetes management and chronic weight control in obese or overweight adults, improving glycemic levels and promoting satiety.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Semaglutide, a GLP-1 receptor agonist available as an injectable solution (e.g., Ozempic, Wegovy), is FDA-approved in the USA for type 2 diabetes and chronic weight management in adults. It requires Boxed Warnings for potential thyroid C-cell tumors and must meet GMP, labeling, and post-marketing surveillance standards. In the EU, semaglutide is centrally approved by the EMA for the same indications, with stringent requirements for Risk Management Plans (RMPs) and pharmacovigilance reporting. Ongoing clinical safety and batch quality oversight are essential in both markets. Explore compliant supply options at Pharmatradz.com.

Semaglutide (Glp-1 Receptor Agonist)2Mg Injectable Solution — third party manufacturing & bulk supply

Semaglutide (Glp-1 Receptor Agonist)2Mg Injectable Solution is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Semaglutide (Glp-1 Receptor Agonist)2Mg Injectable Solution is supplied as Injectable solution (prefilled pen) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Semaglutide (Glp-1 Receptor Agonist)2Mg Injectable Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Semaglutide (Glp-1 Receptor Agonist)2Mg... →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Semaglutide is used to improve blood sugar control in adults with type 2 diabetes mellitus and to aid in chronic weight management for obese or overweight individuals with related health conditions. It helps lower blood glucose levels by stimulating insulin release and reducing appetite.

Semaglutide is a synthetic peptide analogue of human glucagon-like peptide-1 (GLP-1). It is produced through recombinant DNA technology in yeast and modified to resist enzymatic degradation, allowing longer activity in the body.

The main trade names of Semaglutide are Ozempic, Wegovy, and Rybelsus.

Semaglutide is manufactured by Novo Nordisk A/S.

The generic name is Semaglutide.

Brand names include Ozempic (for type 2 diabetes), Wegovy (for weight management), and Rybelsus (oral form for diabetes).

Semaglutide is manufactured by Novo Nordisk in Denmark and also at its production facilities in the United States.

Related Products

Repaglinide

Strength:
0.5 mg, 1 mg, 2 mg

Form: Tablets

Reference Brands: Prandin (USA)

View Details
Pioglitazone Hydrochloride 150Mg Tablet

Strength:
15 mg, 30 mg, 45 mg

Form: Tablets

Reference Brands: Actos (USA)

View Details
Nateglinide

Strength:
60 mg, 120 mg, 180 mg

Form: Tablets

Reference Brands: Starlix (USA)

View Details
Miglitol

Strength:
25 mg, 50 mg, 100 mg

Form: Tablets

Reference Brands: Glyset (USA), Diastabol (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.